Physician profile
James E Ruffer
NPI 1679564629
$928.89
in general payments reported to CMS, 2019-2025
14 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.64 · 2020: $27.31 · 2021: $143 · 2022: $53.95 · 2023: $476 · 2024: $63.77 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $147.56 | 2023-2024 | Varian Ethos Treatment Planning, Truebeam |
| Elekta, INC. | $146.37 | 2023 | Elekta Medical Linear Accelerator |
| Galvanize Therapeutics, INC | $145.70 | 2025 | Aliya System |
| Reflexion Medical, INC. | $135.08 | 2023 | Reflexion Medical Radiotherapy System |
| Accuray Incorporated | $83.35 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.86 | 2020-2023 | |
| Blue Earth Diagnostics | $44.37 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $32.17 | 2022 | |
| Mevion_medical_systems_inc | $30.02 | 2024 | Pts250 |
| Nevro Corp. | $29.97 | 2023 | Senza |
| Canon Medical Systems USA, INC. | $19.30 | 2023 | Ct Scanner |
| Boston Scientific Corporation | $18.64 | 2019 | |
| Viewray Technologies INC | $16.54 | 2021 | |
| Ambu INC. | $5.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ruffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.